Fig. 1From: Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacyONCOS-102 and ONCOS-204 action on tumor cells. A Vehicle, ONCOS-102 and ONCOS-204 plasmids design. A375 tumor cells GM-CSF production (B) and ICOSL production (C) and surface expression (D, E) 24, 48 and 72 h after infection with different concentrations of ONCOS-102 or ONCOS-204 viral particles/target cells (vp/target cells)Back to article page